Assessing Telomerase Activities in Mammalian Cells Using the Quantitative PCR-Based Telomeric Repeat Amplification Protocol (qTRAP)

Author(s):  
Shuai Jiang ◽  
Mengfan Tang ◽  
Huawei Xin ◽  
Junjiu Huang
BioTechniques ◽  
1998 ◽  
Vol 24 (5) ◽  
pp. 726-728 ◽  
Author(s):  
Loryn N. Sellner ◽  
Peta M. Lock ◽  
Gavin R. Turbett

2010 ◽  
Vol 71 (12) ◽  
pp. 1468-1474 ◽  
Author(s):  
Angela L. McCleary-Wheeler ◽  
Laurel E. Williams ◽  
Paul R. Hess ◽  
Steven E. Suter

1997 ◽  
Vol 19 (4) ◽  
pp. 451-457 ◽  
Author(s):  
Y. Wada ◽  
A. Yagihashi ◽  
H. Kameshima ◽  
A. Matsuura ◽  
N. Sato ◽  
...  

BioTechniques ◽  
1997 ◽  
Vol 23 (6) ◽  
pp. 1029-1032 ◽  
Author(s):  
Dunne Fong ◽  
James P. Burke ◽  
Marion Man-Ying Chan

2013 ◽  
Vol 66 (5) ◽  
pp. 530 ◽  
Author(s):  
Tsz-Ying Yuen ◽  
Yu-Pong Ng ◽  
Fanny C. F. Ip ◽  
Jack L.-Y. Chen ◽  
Darcy J. Atkinson ◽  
...  

Twenty nine novel spiroketal derivatives related to the rubromycins were evaluated for their anti-telomerase activity using the real-time quantitative telomeric repeat amplification protocol assay. The parent compound γ-rubromycin exhibited the highest potency against human telomerase activity within the series. Modification of the spiroketal motif by the introduction of heteroatoms and substituents at different positions produced analogues with varying bioactivity. Variation at the isocoumarin subunit of the title compound resulted in weaker activity, indicative of its importance in telomerase inhibition.


Sign in / Sign up

Export Citation Format

Share Document